Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Blandin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|January 23, 2026
Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell NichesYan Cui, Jasmine Blandin, Kipp Weiskopf, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphomaJuliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
The Journal of Clinical Investigation|March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destructionKyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
CD47 predominates over CD24 as a macrophage immune checkpoint in cancerJuliet Allen, Anna Meglan, Kyle Vaccaro, et al.
Cancer Cell|December 13, 2024
Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skinHeehwa G Son, Dat Thinh Ha, Yun Xia, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|January 23, 2026
Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell NichesYan Cui, Jasmine Blandin, Kipp Weiskopf, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphomaJuliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
The Journal of Clinical Investigation|March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destructionKyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
CD47 predominates over CD24 as a macrophage immune checkpoint in cancerJuliet Allen, Anna Meglan, Kyle Vaccaro, et al.
Cancer Cell|December 13, 2024
Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skinHeehwa G Son, Dat Thinh Ha, Yun Xia, et al.
Pageof 1